Introduction: Oncocytic neoplasms as tumors arising in the adrenal glands are rare, usually considered as nonfunctional and benign. In the current literature, there are extremely limited reports of adrenal oncocytic neoplasms; as to date, only 147 cases have been described. The rarity of the event prompted this study which reviews and presents the incidence, histology, diagnosis and therapy of adrenal oncocytic neoplasms. Materials and Methods: A review by systematic literature search was done using the MEDLINE®/Cochrane libraries from 1950 to date using the medical subject headings ‘oncocytoma', ‘adrenal gland', ‘adrenal oncocytoma', ‘adrenal oncocytic neoplasm' and ‘adrenal oncocytic carcinoma'. Results: Adrenal oncocytic neoplasm is a rare disease, usually incidentally detected because only 17% are functional adrenal masses. The typical oncocyte displays abundant granular eosinophilic cytoplasm, due to the accumulation of mitochondria. Computed tomography and magnetic resonance imaging are not able to identify or differentiate benign and malignant oncocytic neoplasms. The mainstay of therapy is adrenalectomy, recently performed by laparoscopy. The prognosis is good for benign tumors, while adrenocortical oncocytic carcinoma has a poor survival rate of only 5 years. Conclusions: Adrenal oncocytic neoplasm, a rare and mostly benign tumor, usually presents as an incidental, large adrenal mass; surgery is the mainstay of therapy, by means of laparoscopy which is now the most diffuse approach to adrenalectomy.

Keywords:
Oncocytoma, Adrenal gland, Adrenal oncocytic neoplasm
1.
Chang A, Harawi SJ: Oncocytes, oncocytosis, and oncocytic tumors. Pathol Annu 1992;27:263-304.
2.
Tallini G: Oncocytic tumours. Virchows Arch 1998;1:5-12.
3.
Tsuta K, Kalhor N, Raso MG, Wistuba II, Moran CA: Oncocytic neuroendocrine tumors of the lung: histopathologic spectrum and immunohistochemical analysis of 15 cases. Hum Pathol 2011;42:578-585.
4.
Kozakiewicz J, Teodorowicz E, Haczyńska-Partyka A, Myrcik G, Lange D, Szwabowicz M: Adenoma oxyphillicum, an extremely rare case of tumour of the larynx end cancer lungs which are going together. Otolaryngol Pol 2007;61:311-314.
5.
Sav A, Scheithauer BW, Mazzola CA, Ketterling SR, Thompson SJ, Reilly MH: Oncocytic choroid plexus carcinoma: case report. Clin Neuropathol 2010;29:14-20.
6.
Kakimoto S, Yushita Y, Sanefuji T, Kondo A, Fujishima N, Kishikawa M, Matsumoto K: Non-hormonal adrenocortical adenoma with oncocytoma-like appearances. Hinyokika Kiyo 1986;32:757-763.
7.
Smirnova EA, Mikhailov IG: Electron microscopic characteristics of oncocytoma of the lung, small intestine and adrenal gland. Arkh Patol 1986;48:79-81.
8.
Bisceglia M, Ludovico O, Di Mattia A, Ben-Dor D, Sandbank J, Pasquinelli G, Lau SK, Weiss LM: Adrenocortical oncocytic tumors: report of 10 cases and review of the literature. Int J Surg Pathol 2004;12:231-243.
9.
Shah VN, Premkumar A, Walia R, Kumar S, Nahar U, Bhansali A: Large but benign adrenal mass: adrenal oncocytoma. Indian J Endocrinol Metab 2012;16:469-471.
10.
Young WF Jr: Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 2007;356:601-610.
11.
de Krijger RR, Papathomas TG: Adrenocortical neoplasia: evolving concepts in tumorigenesis with an emphasis on adrenal cortical carcinoma variants. Virchows Arch 2012;460:9-18.
12.
Thway K, Olmos D, Shah C, Flora R, Shipley J, Fisher C: Oncocytic adrenal cortical carcinosarcoma with pleomorphic rhabdomyosarcomatous metastases. Am J Surg Pathol 2012;36:470-477.
13.
Lee R, Al-Ahmadie HA, Boorjian SA, Gonzalez RR, Badillo C, Badillo F, Reuter VE, Steckel J: A case of incidental adrenocortical oncocytoma. Nat Clin Pract Urol 2006;3:618-621.
14.
Vara Castrodeza A, Ablanedo Ablanedo P, García García J, Martínez Lara C, Díaz A, Calvo Blanco J: Adrenal oncocytoma. Arch Esp Urol 1999;52:525-528.
15.
Kitching PA, Patel V, Harach HR: Adrenocortical oncocytoma. J Clin Pathol 1999;52:151-153.
16.
Macchi C, Rebuffat P, Blandamura S, Piazza M, Macchi V, Fiore D, Nussdorfer GG: Adrenocortical oncocytoma: case report and review of the literature. Tumori 1998;84:403-407.
17.
Bégin LR: Adrenocortical oncocytoma: case report with immunocytochemical and ultrastructural study. Virchows Arch A Pathol Anat Histopathol 1992;421:533-537.
18.
Sasano H, Suzuki T, Sano T, Kameya T, Sasano N, Nagura H: Adrenocortical oncocytoma. A true nonfunctioning adrenocortical tumor. Am J Surg Pathol 1991;15:949-956.
19.
Wong DD, Spagnolo DV, Bisceglia M, Havlat M, McCallum D, Platten MA: Oncocytic adrenocortical neoplasms - a clinicopathologic study of 13 new cases emphasizing the importance of their recognition. Hum Pathol 2011;42:489-499.
20.
Corsi A, Riminucci M, Petrozza V, Collins MT, Natale ME, Cancrini A, Bianco P: Incidentally detected giant oncocytoma arising in retroperitoneal heterotopic adrenal tissue. Arch Pathol Lab Med 2002;126:1118-1122.
21.
Nguyen GK, Vriend R, Ronaghan D, Lakey WH: Heterotopic adrenocortical oncocytoma. A case report with light and electron microscopic studies. Cancer 1992;70:2681-2684.
22.
Segal S, Cytron S, Shenhav S, Gemer O: Adrenocortical oncocytoma in pregnancy. Obstet Gynecol 2001;98:916-918.
23.
Krech R, Zerban H, Bannasch P: Mitochondrial anomalies in renal oncocytes induced in rats by N-nitrosomorpholine. Eur J Cell Biol 1981;25:331-339.
24.
Sun CN, White HV, Thompson BW: Oncocytoma (mitochondrioma) of the parotid gland. Arch Pathol 1975;99:208-214.
25.
Duregon E, Volante M, Cappia S, Cuccurullo A, Bisceglia M, Wong DD, Spagnolo DV, Szpak-Ulczok S, Bollito E, Daffara F, Berruti A, Terzolo M, Papotti M: Oncocytic adrenocortical tumors: diagnostic algorithm and mitochondrial DNA profile in 27 cases. Am J Surg Pathol 2011;35:1882-1893.
26.
Hartwick RW, Batsakis JG: Non-Warthin's tumor oncocytic lesions. Ann Otol Rhinol Laryngol 1990;99:674-677.
27.
Hamperl H: Oncocytes and the so-called Hurthle cell tumor. Arch Pathol 1950;49:563-570.
28.
Seo IS, Henley JD, Min KW: Peculiar cytoplasmic inclusions in oncocytic adrenal cortical tumors: an electron microscopic observation. Ultrastruct Pathol 2002;26:229-235.
29.
Hoang MP, Ayala AG, Albores-Saavedra J: Oncocytic adrenocortical carcinoma: a morphologic, immunohistochemical and ultrastructural study of four cases. Mod Pathol 2002;15:973-978.
30.
Lin BT, Bonsib SM, Mierau GW, Weiss LM, Medeiros LJ: Oncocytic adrenocortical neoplasms: a report of seven cases and review of the literature. Am J Surg Pathol 1998;22:603-614.
31.
Ohtake H, Kawamura H, Matsuzaki M, Yokoyama E, Kitajima M, Onizuka S, Yamakawa M: Oncocytic adrenocortical carcinoma. Ann Diagn Pathol 2010;14:204-208.
32.
Lázaro Santander R, Andrés Gozalbo C, Cortés Vizcaíno V, Vera Román JM: Low-grade oncocytic adrenal carcinoma. Arch Esp Urol 2001;54:1123-1126.
33.
Chisté M, Poppiti RJ, Bianco FJ: Oncocytoma of the adrenal gland medulla. Ann Diagn Pathol 2011, E-pub ahead of print.
34.
Sangoi RS, McKenney JK: A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma. Am J Surg Pathol 2010;32:423-432.
35.
Schittenhelm J, Ebner FH, Harter P, Bornemann A: Symptomatic intraspinal oncocytic adrenocortical adenoma. Endocr Pathol 2009;20:73-77.
36.
Gołkowski F, Buziak-Bereza M, Huszno B, Bałdys-Waligórska A, Stefańska A, Budzyński A, Okoń K, Chrzan R, Urbanik A: The unique case of adrenocortical malignant and functioning oncocytic tumour. Exp Clin Endocrinol Diabetes 2007;115:401-404.
37.
Botsios D, Blouhos K, Vasiliadis K, Asimaki A, Tsalis K, Betsis D: Adrenocortical oncocytoma - a rare tumor of undefined malignant potential: report of a case. Surg Today 2007;37:612-617.
38.
Lázaro Santander R, Andrés Gozalbo C, Cortés Vizcaíno V, Vera Román JM: Low-grade oncocytic adrenal carcinoma. Arch Esp Urol 2001;54:1123-1126.
39.
el-Naggar AK, Evans DB, Mackay B: Oncocytic adrenal cortical carcinoma. Ultrastruct Pathol 1991;15:549-556.
40.
Argyriou P, Zisis C, Alevizopoulos N, Kefaloyannis EM, Gennatas C, Petraki CD: Adrenocortical oncocytic carcinoma with recurrent metastases: a case report and review of the literature. World J Surg Oncol 2008;6:134-139.
41.
Juliano JJ, Cody RL, Suh JH: Metastatic adrenocortical oncocytoma: a case report. Urol Oncol 2008;26:198-201.
42.
Song SY, Park S, Kim SR, Suh YL: Oncocytic adrenocortical carcinomas: a pathological and immunohistochemical study of four cases in comparison with conventional adrenocortical carcinomas. Pathol Int 2004;54:603-610.
43.
Medeiros LJ, Weiss LM: New developments in the pathologic diagnosis of adrenal cortical neoplasms. A review. Am J Clin Pathol 1992;97:73-83.
44.
Sasano H, Suzuki T, Moriya T: Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma. Endocr Pathol 2006;17:345-354.
45.
Angeli A, Osella G, Ali A, Terzolo M: Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group. Horm Res 1997;47:279-283.
46.
Reyna-Villasmil E, Santos-Bolívar J, Prieto-Montaño J: Adrenal oncocytoma. Cir Esp 2011;89:692-693.
47.
Osman Y, El-Mekresh M, Gomha AM, Mohsen T, Taha N, Hussein N, Eraky I: Percutaneous adrenal biopsy for indeterminate adrenal lesion: complications and diagnostic accuracy. Urol Int 2010;84:315-318.
48.
Kiriakopoulos A, Papaioannou D, Linos D: Adrenal cortical oncocytoma mimicking pheochromocytoma. Hormones (Athens) 2011;10:76-79.
49.
Sharma N, Dogra PN, Mathur S: Functional adrenal oncocytoma: a rare neoplasm. Indian J Pathol Microbiol 2008;51:531-533.
50.
Goel T, Thomas J, Garg S, Rao AC, Reddy S: Adrenal oncocytoma masquerading as a functional tumor. Indian J Urol 2007;23:77-78.
51.
Li M, Wenig BM: Adrenal oncocytic pheochromocytoma. Am J Surg Pathol 2000;24:1552-1557.
52.
Lee SS, Baek KH, Lee YS, Lee JM, Kang MI, Cha BY, Lee KW, Son HY, Kang SK: Subclinical Cushing's syndrome associated with an adrenocortical oncocytoma. J Endocrinol Invest 2008;31:675-679.
53.
Geramizadeh B, Norouzzadeh B, Bolandparvaz S, Sefidbakht S: Functioning adrenocortical oncocytoma: a case report and review of literature. Indian J Pathol Microbiol 2008;51:237-239.
54.
Xiao GQ, Pertsemlidis DS, Unger PD: Functioning adrenocortical oncocytoma: a case report and review of the literature. Ann Diagn Pathol 2005;9:295-297.
55.
Kabayegit OY, Soysal D, Oruk G, Ustaoglu B, Kosan U, Solmaz S, Avci A: Adrenocortical oncocytic neoplasm presenting with Cushing's syndrome: a case report. J Med Case Rep 2008;2:228.
56.
Alexander A, Paulose KP: Oncocytic variant of adrenal carcinoma presenting as Cushing's syndrome. J Assoc Physicians India 1998;46:235-237.
57.
Terui K, Sakihara S, Kageyama K, Nigawara T, Takayasu S, Matsuhashi Y, Kon A, Yamamoto H, Ohyama C, Sasano H, Suda T: A case of adrenocortical oncocytoma occurring with aldosteronoma. J Clin Endocrinol Metab 2010;95:3597-3598.
58.
Mete O, Asa SL: Aldosterone-producing adrenal cortical adenoma with oncocytic change and cytoplasmic eosinophilic globular inclusions. Endocr Pathol 2009;20:182-185.
59.
Lim YJ, Lee SM, Shin JH, Koh HC, Lee YH: Virilizing adrenocortical oncocytoma in a child: a case report. J Korean Med Sci 2010;25:1077-1079.
60.
Gumy-Pause F, Bongiovanni M, Wildhaber B, Jenkins JJ, Chardot C, Ozsahin H: Adrenocortical oncocytoma in a child. Pediatr Blood Cancer 2008;50:718-721.
61.
Ciprová V, Povýsil C, Dudorkinová D, Safarík L, Zelinka T: Oncocytic adrenocortical neoplasms. Cesk Patol 2004;40:102-105.
62.
Erlandson RA, Reuter VE: Oncocytic adrenal cortical adenoma. Ultrastruct Pathol 1991;15:539-547.
63.
Mwandila M, Waller H, Stott V, Mercer P: A case of a testosterone-secreting oncocytic adrenocortical carcinoma. N Z Med J 2010;123:80-82.
64.
Tahar GT, Nejib KN, Sadok SS, Rachid LM: Adrenocortical oncocytoma: a case report and review of literature. J Pediatr Surg 2008;43:E1-E3.
65.
Logasundaram R, Parkinson C, Donaldson P, Coode PE: Co-secretion of testosterone and cortisol by a functional adrenocortical oncocytoma. Histopathology 2007;51:418-420.
66.
Ali AE, Raphael SJ: Functional oncocytic adrenocortical carcinoma. Endocr Pathol 2007;18:187-189.
67.
Akatsu T, Kameyama K, Araki K, Ashizawa T, Wakabayashi G, Kitajima M: Functioning adrenocortical oncocytoma: the first documented case producing interleukin-6 and review of the literature. J Endocrinol Invest 2008;31:68-73.
68.
Tirkes T, Gokaslan T, McCrea J, Sandrasegaran K, Hollar MA, Akisik F, Lall C: Oncocytic neoplasms of the adrenal gland. AJR Am J Roentgenol 2011;196:592-596.
69.
Boland GWL: Adrenal imaging. Abdom Imaging 2011;36:472-482.
70.
Shah RK, Oto A, Ozkan OS, Ernst RD, Hernandez JA, Chaudhary HB, Koroglu M: Adrenal oncocytoma: US and CT findings. JBR-BTR 2004;87:180-182.
71.
Poretti D, Mazzarol G, Bonomo G, Casadio C, Bellomi M: Adrenocortical oncocytoma: case report. Clin Imaging 2003;27:426-430.
72.
Park BK, Kim B, Ko K, Jeong SY, Kwon GY: Adrenal masses falsely diagnosed as adenomas on unenhanced and delayed contrast-enhanced computed tomography: pathological correlation. Eur Radiol 2006;16:642-647.
73.
Haider MA, Ghai S, Jhaveri K, Lockwood G: Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role? Radiology 2004;231:711-716.
74.
Savci G, Yazici Z, Sahin N, Akgöz S, Tuncel E: Value of chemical shift subtraction MRI in characterization of adrenal masses. AJR Am J Roentgenol 2006;186:130-135.
75.
Monk IP, Lahiri R, Sivaprakasam R, Malhotra S, Praseedom RK, Jah A: Adrenocortical oncocytoma: review of imaging and histopathological implications. Int J Surg Case Rep 2010;1:30-32.
76.
Kekis P, Seretis C, Lagoudianakis E, Gemenetzis G, Koronakis N, Keramidaris D, Manouras I, Manouras A: Laparoscopic approach to a large adrenocortical oncocytoma: a case report and review of the literature. Int J Surg Case Rep 2012;3:279-282.
77.
Rosenkrantz AB, Do RK, Hajdu CH: Imaging appearance of bulk fat within an oncocytic adrenocortical neoplasm, a rare and potentially malignant tumour. Br J Radiol 2010;83:204-207.
78.
Friedrich-Rust M, Glasemann T, Polta A, Eichler K, Holzer K, Kriener S, Herrmann E, Nierhoff J, Bon D, Bechstein WO, Vogl T, Zeuzem S, Bojunga J: Differentiation between benign and malignant adrenal mass using contrast-enhanced ultrasound. Ultraschall Med 2011;32:460-471.
79.
Kim DJ, Chung JJ, Ryu YH, Hong SW, Yu JS, Kim JH: Adrenocortical oncocytoma displaying intense activity on 18F-FDG-PET: a case report and a literature review. Ann Nucl Med 2008;22:821-824.
80.
Acar C, Akkas BE, Sen I, Sozen S, Kitapci MT: False positive 18F-FDG PET scan in adrenal oncocytoma. Urol Int 2008;80:444-447.
81.
Minamimoto R, Yamanaka S, Kawamoto M, Endoh M, Nishito R, Yoshida K, Nakaigawa N, Yao M, Kubota Y, Inoue T: High FDG uptake on oncocytoma located in the retroperitoneum mimicking malignancy. Clin Nucl Med 2007;32:582-583.
82.
Padberg BC, Rordorf T, Suter SL, Pfeiffer D, Wild D, Schröder S: 123I-Metaiodobenzylguanidine (MIBG) scintigraphy: paradoxical positivity in an oncocytic adrenocortical carcinoma. Pathologe 2007;28:281-284.
83.
Krishnamurthy S, Ordonez NG, Shelton TO, Ayala AG, Sneige N: Fine-needle aspiration cytology of a case of oncocytic adrenocortical carcinoma. Diagn Cytopathol 2000;22:299-303.
84.
Cham E, Watkin W, Goldschmidt R, Liu L: Fine needle aspiration cytology of adrenocortical oncocytic neoplasm: a case report. Acta Cytol 2010;54:627-634.
85.
Wragg T, Nguyen GK: Cytopathology of adrenal cortical oncocytoma. Diagn Cytopathol 2001;24:222-223.
86.
Lee CK, Choi KH, Cha YJ, Bum JH, Lee HH, Kim MS, Park WK, Yang SC, Han WK: Large oncocytic adrenocortical tumor with uncertain malignant potential. Korean J Urol 2011;52:650-652.
87.
Farah-Klibi F, Ben Slama S, Ferchichi L, Ben Temime L, Ben Jilani S, Zermani R: Adrenal gland oncocytoma. Tunis Med 2011;89:309-310.
88.
Bouasker I, Zoghlami A, Farah Klibi F, Smaali I, El Ouaer MA, Zermani R, Dziri C: Adreno-cortical oncocytoma: a case report. Tunis Med 2010;88:353-356.
89.
Pazooki A, Vaziri M: Incidental adrenocortical oncocytoma. BMJ Case Rep DOI: 10.1136/bcr.12.2008.1405.
90.
Tian XJ, Huang Y, Lu J, Ma LL: Laparoscopic adrenocortical oncocytoma resection. Chin Med J 2008;121:862-864.
91.
Eldahshan S, Celia A, Zeccolini G, Guerini A, Breda G: Laparoscopic transperitoneal adrenalectomy for adrenocortical oncocytoma. Arch Ital Urol Androl 2008;80:82-84.
92.
Farkas A, Horányi J, Gláz E, Kulka J: Oncocytic tumor of the adrenal gland. Orv Hetil 2005;146:1453-1458.
93.
Young JA, Chapman WH 3rd, Kim VB, Albrecht RJ, Ng PC, Nifong LW, Chitwood WR Jr: Robotic-assisted adrenalectomy for adrenal incidentaloma: case and review of the technique. Surg Laparosc Endosc Percutan Tech 2002;12:126-130.
94.
Modi P, Goel R, Kadam G: Retroperitoneoscopic partial adrenalectomy for large adrenocortical oncocytoma. J Endourol 2007;21:419-422.
95.
Thway K, Olmos D, Shah C, Flora R, Shipley J, Fisher C: Oncocytic adrenal cortical carcinosarcoma with pleomorphic rhabdomyosarcomatous metastases. Am J Surg Pathol 2012;36:470-477.
96.
Allolio B, Fassnacht M: Clinical review: adrenocortical carcinoma. J Clin Endocrinol Metab 2006;91:2027-2037.
97.
Kurek R, Von Knobloch R, Feek U, Heidenreich A, Hofmann R: Local recurrence of an oncocytic adrenocortical carcinoma with ovary metastasis. J Urol 2001;166:985.
98.
Terzolo M, Angeli A, Fassnacht M: Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med 2007;356:2372-2380.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.